1. Home
  2. TALKW vs SCLXW Comparison

TALKW vs SCLXW Comparison

Compare TALKW & SCLXW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Talkspace Inc. Warrant

TALKW

Talkspace Inc. Warrant

HOLD

Current Price

$0.00

Market Cap

0.0

Sector

Health Care

ML Signal

HOLD

Logo Scilex Holding Company

SCLXW

Scilex Holding Company

HOLD

Current Price

$0.17

Market Cap

0.0

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
TALKW
SCLXW
Founded
2012
N/A
Country
United States
United States
Employees
598
34
Industry
Medical/Nursing Services
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
N/A
N/A
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
TALKW
SCLXW
Price
$0.00
$0.17
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
166.5K
2.9K
Earning Date
02-20-2025
03-07-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$181,291,000.00
$55,152,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
31.50
22.02
52 Week Low
$0.00
$0.05
52 Week High
$0.10
$0.64

Technical Indicators

Market Signals
Indicator
TALKW
SCLXW
Relative Strength Index (RSI) 37.46 53.30
Support Level N/A $0.11
Resistance Level $0.01 $0.18
Average True Range (ATR) 0.00 0.02
MACD -0.00 0.00
Stochastic Oscillator 0.00 76.94

Price Performance

Historical Comparison
TALKW
SCLXW

About TALKW Talkspace Inc. Warrant

Talkspace Inc is a virtual behavioral healthcare company offering its members convenient and affordable access to a fully-credentialed network of qualified providers across a wide and growing spectrum of care through virtual psychotherapy and psychiatry. It is a single destination for comprehensive mental health care, including therapy for individuals, couples, and teens, as well as psychiatric treatment and medication management (18+), and self-guided tools and resources. The company's customers include Health insurance plans from commercial and government institutions, and employee assistance programs, Direct-to-Enterprise, and Individual subscribers. The company operates as a single segment.

About SCLXW Scilex Holding Company

Scilex Holding Co is focused on acquiring, developing and commercializing non-opioid pain management products for the treatment of acute and chronic pain. It targets indications with high unmet needs and large market opportunities with non-opioid therapies for the treatment of patients with acute and chronic pain and are dedicated to advancing and improving patient outcomes. Its commercial products are: ZTlidoO for the relief of neuropathic pain associated with postherpetic neuralgia (PHN), which is a form of post-shingles nerve pain; ELYXYB, a potential first-line treatment ready-to-use oral solution for the acute treatment of migraine in adults and GLOPERBA, the liquid oral version of the anti-gout medicine colchicine indicated for the prophylaxis of painful gout flares in adults.

Share on Social Networks: